Online citations, reference lists, and bibliographies.
← Back to Search

Design Of Hybrid MnO2‐Polymer‐Lipid Nanoparticles With Tunable Oxygen Generation Rates And Tumor Accumulation For Cancer Treatment

C. Gordijo, A. Z. Abbasi, M. A. Amini, Ho Yin Lip, Azusa Maeda, Ping Cai, P. J. O'Brien, Ralph S Dacosta, Ralph S Dacosta, A. M. Rauth, X. Wu
Published 2015 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Manganese dioxide (MnO2) nanoparticles (NPs) were discovered in previous work to be effective in improving tumor oxygenation (hypoxia) and reducing H2O2 and acidity in the tumor microenvironment (TME) via local injection. To develop MnO2 formulations useful for clinical application, hybrid NPs are designed with tailored hydrophobicity and structure suitable for intravenous injection, with good blood circulation, biocompatibility, high tumor accumulation, and programmable oxygen generation rate. Two different hybrid NPs are constructed by embedding polyelectrolyte-MnO2 (PMD) in hydrophilic terpolymer/protein-MnO2 (TMD) or hydrophobic polymer/lipid-MnO2 (LMD) matrices. The in vitro reactivity of the MnO2 toward H2O2 is controlled by matrix material and NP structure and dependent on pH with up to two-fold higher O2 generation rate at acidic (tumor) pH than at systemic pH. The hybrid NPs are found to be safe to cells in vitro and organs in vivo and effectively decrease tumor hypoxia and hypoxia-inducible-factor-1alpha through local or systemic administration. Fast acting TMD reduces tumor hypoxia by 70% in 0.5 h by local injection. Slow acting LMD exhibits superior tumor accumulation and retention through the systemic administration and decreased hypoxia by 45%. These findings encourage a broader use of hybrid MD NPs to overcome TME factors for cancer treatment.
This paper references
Studies on liver damage induced by nanosized-titanium dioxide in mouse.
Y. Jeon (2013)
10.1021/mp200292c
Drug resistance and cellular adaptation to tumor acidic pH microenvironment.
Jonathan W. Wojtkowiak (2011)
10.1021/mp500093c
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
Adam J Shuhendler (2014)
10.1111/j.1582-4934.2009.00994.x
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
J. Chiche (2010)
10.1667/RR3515.1
Dynamics of Hypoxia, Proliferation and Apoptosis after Irradiation in a Murine Tumor Model
A. Ljungkvist (2006)
10.1002/JPS.20100
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.
H. L. Wong (2004)
10.4137/BMI.S2185
Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
L. L. de Matos (2010)
10.1038/nrc2344
Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability
R. Bristow (2008)
20 , 1404 ; b)
C R Gordijo (2010)
10.1124/jpet.106.101154
A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System
H. L. Wong (2006)
11 , 2659 ; b)
A J Shuhendler (2013)
10.1186/bcr2642
Antiangiogenic therapy for breast cancer
D. Nielsen (2010)
10.4049/jimmunol.0801124
NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment1
A. Mailloux (2009)
10.2174/156652409788167087
Hypoxia and radiation therapy: past history, ongoing research, and future promise.
S. Rockwell (2009)
10.1002/ADFM.200901581
Glucose‐Responsive Bioinorganic Nanohybrid Membrane for Self‐Regulated Insulin Release
C. Gordijo (2010)
10.1146/ANNUREV.EARTH.32.101802.120213
Biogenic manganese oxides: Properties and mechanisms of formation
B. Tebo (2004)
10.1002/adma.201303161
25th anniversary article: metal oxide particles in materials science: addressing all length scales.
D. Koziej (2014)
10.1155/2013/485196
Investigating Mechanisms of Alkalinization for Reducing Primary Breast Tumor Invasion
I. Robey (2013)
11 , 167 ; b)
S E Rademakers (2009)
10.1039/c0cs00127a
Manganese oxide-based materials as electrochemical supercapacitor electrodes.
W. Wei (2011)
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
J. Brown (1998)
Radiosensitivity uncertainty evaluation for the in vitro biophysical modeling of EMT6 cells.
M. Oita (2014)
2 , 320 ; f)
A Pottier (2013)
10.20772/CANCERSCI1985.77.10_1027
An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Y. Shibamoto (1986)
10.1016/j.ijpharm.2009.10.011
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
K. Teskač (2010)
10.1016/J.NANTOD.2011.10.001
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
10.1002/ijc.27666
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α
Y. Kim (2013)
10.1016/j.ijpharm.2010.09.025
Nanosponge formulations as oxygen delivery systems.
Roberta Cavalli (2010)
10.1038/nrclinonc.2012.64
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
A. Rapisarda (2012)
10.1016/j.canlet.2012.08.008
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts.
P. Prasad (2013)
10.1007/s10555-012-9394-4
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
E. Fokas (2012)
10.1186/1556-276X-9-117
ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes
Jieting Wang (2014)
10.1016/j.ejpb.2012.09.001
pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
A. Shalviri (2012)
Cells Blood Substit
J. W. Wojtkowiak (2011)
10.1016/j.tibtech.2008.04.005
Multifunctional nanoparticles--properties and prospects for their use in human medicine.
Nuria Sanvicens (2008)
10.1002/ADFM.201001762
Nanotechnology‐Enabled Closed Loop Insulin Delivery Device: In Vitro and In Vivo Evaluation of Glucose‐Regulated Insulin Release for Diabetes Control
C. Gordijo (2011)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1200/JCO.2012.41.9242
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
J. Bottsford-Miller (2012)
10.1016/j.nano.2013.01.005
Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation.
Adam J. Shuhendler (2013)
10.1158/1078-0432.CCR-11-2711
Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
M. Milosevic (2012)
10.1007/s11095-006-0282-x
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
10.1002/adma.201200653
Hybrid nanoparticles for detection and treatment of cancer.
M. Sailor (2012)
10.4161/cbt.8.21.9988
Modulating the tumor microenvironment to increase radiation responsiveness
J. Karar (2009)
10.1038/nrclinonc.2012.127-c1
The microenvironment and resistance to personalized cancer therapy
S. Masuda (2013)
10.3978/J.ISSN.2218-676X.2013.08.04
Improving chemoradiotherapy with nanoparticle therapeutics.
M. Eblan (2013)
10.1111/j.1365-2559.2006.02513.x
Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II
C. Taylor (2006)
10.1016/J.BIOS.2003.11.019
A novel glucose ENFET based on the special reactivity of MnO2 nanoparticles.
X. Luo (2004)
10.2217/nnm.10.50
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.
Sarah R MacEwan (2010)
10.1002/adma.201000717
Beyond intercalation-based Li-ion batteries: the state of the art and challenges of electrode materials reacting through conversion reactions.
J. Cabana (2010)
8 , 705 ; d)
A NCSDenko (2006)
10.1166/JNN.2010.2682
Nano titanium dioxide induces the generation of ROS and potential damage in HaCaT cells under UVA irradiation.
Chengbin Xue (2010)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1016/S0926-860X(98)00430-X
Promotion of the hydrogen peroxide decomposition activity of manganese oxide catalysts
M. A. Hasan (1999)
10.1002/jat.2887
Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure
S. Singh (2013)
10.1016/j.jconrel.2012.01.027
Safety assessment of nanomaterials: implications for nanomedicine.
Andreas M. Nystroem (2012)
59 , 491 ; b)
H L Wong
10.1166/JNN.2010.1719
Mechanism for α -MnO 2 Nanowire-Induced Cytotoxicity in Hela Cells
Y. Li (2010)
New use of metals as nanosized radioenhancers.
A. Pottier (2014)
10.1667/RR2773.1
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
H. Park (2012)
10.1038/nbt1220
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging
H. Zhang (2006)
10.1016/J.JCONREL.2006.09.007
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
H. L. Wong (2006)
10.1080/10731190903043218
Hemoglobin-based Oxygen Carriers Combined with Anticancer Drugs May Enhance Sensitivity of Radiotherapy and Chemotherapy to Solid Tumors
W. Wu (2009)
10.1016/J.IJPHARM.2007.07.012
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
H. Yuan (2008)
10.1111/jcmm.12004
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
M. Mimeault (2013)
10.1038/nrc2981
Regulation of cancer cell metabolism
R. Cairns (2011)
10.1021/nn501069c
A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer.
J. Li (2014)
10.1039/c4cc07644c
Nanoparticle-blood interactions: the implications on solid tumour targeting.
James Lazarovits (2015)
10.4137/BMI.S14481
The Range of Uncertainty: a Tool for Efficiently Addressing Result Variability Around Clinical Decision Points for Hepatitis C Response-guided Therapy
P. Jülicher (2014)
31 , 823 ; b) J. Karar , A. Maity
E Fokas (1994)
10.2174/156652409789839107
Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment.
E. Shinohara (2009)
10.1016/j.colsurfb.2012.07.015
Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin.
A. Shalviri (2013)
10.1093/JNCI/DJM135
Drug resistance and the solid tumor microenvironment.
O. Trédan (2007)
10.2174/138161210791920496
Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.
Jin-Wook Yoo (2010)
10.1155/2014/379748
Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System
A. Maruf (2014)
10.1038/nrc2468
Hypoxia, HIF1 and glucose metabolism in the solid tumour
N. Denko (2008)
10.1021/CM980227H
A Review of Porous Manganese Oxide Materials
S. Brock (1998)
10.1016/J.ADDR.2007.04.008
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
H. L. Wong (2007)
10.1002/adhm.201200006
A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Adam J Shuhendler (2012)
10.1038/nrc2255
A microenvironmental model of carcinogenesis
R. Gatenby (2008)
10.1021/nn405773r
Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
P. Prasad (2014)
10.1016/S0014-5793(00)02197-9
Hydrogen peroxide in the human body
B. Halliwell (2000)
10.1016/j.jconrel.2013.01.014
Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor.
A. Shalviri (2013)



This paper is referenced by
10.1016/j.colsurfb.2017.07.081
Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.
J. Bizeau (2017)
10.1016/j.bios.2018.07.040
A novel pH-responsive electrochemiluminescence immunosensor for ALV-J detection based on hollow MnO2 encapsulating Ru(bpy)3Cl2.
C. Liu (2018)
10.1093/nsr/nwaa160
Advances in nanomaterials for treatment of hypoxic tumor
Mei-Zhen Zou (2020)
10.1002/smll.201804131
Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
Zhimei He (2019)
10.1016/j.biomaterials.2018.10.018
A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback.
Jintong Liu (2019)
10.1007/S11434-015-0829-5
Construction of smart inorganic nanoparticle-based ultrasound contrast agents and their biomedical applications
M. Ma (2015)
10.1016/j.biomaterials.2020.120228
Specific-oxygen-supply functionalized core-shell nanoparticles for smart mutual-promotion between photodynamic therapy and gambogic acid-induced chemotherapy.
Lingfei Han (2020)
10.1039/C9NJ00941H
A heavy atom-free copolymer for light triggered photodynamic and photothermal therapy of human prostate cancer cells
Jian Shen (2019)
10.1002/adhm.201900047
Targeted Magnetic Resonance Imaging and Modulation of Hypoxia with Multifunctional Hyaluronic Acid-MnO2 Nanoparticles in Glioma.
Chaoping Fu (2019)
10.1002/adtp.201900181
Reprogramming Tumor Associated Macrophages toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy
X. Xu (2020)
10.1016/j.biomaterials.2020.120314
Injectable redox and light responsive MnO2 hybrid hydrogel for simultaneous melanoma therapy and multidrug-resistant bacteria-infected wound healing.
S. Wang (2020)
10.1007/s13233-018-6067-3
Functional Graphene Oxide-Based Nanosheets for Photothermal Therapy
J. H. Lim (2018)
10.1002/adtp.201900083
Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy
Jinping Wang (2020)
10.1039/c9tb02341k
Albumin-stabilized manganese-based nanocomposites with sensitive tumor microenvironment responsivity and their application for efficient SiRNA delivery in brain tumors.
K. Xu (2020)
10.1021/acsnano.5b04606
Bottom-Up Synthesis of Metal-Ion-Doped WS₂ Nanoflakes for Cancer Theranostics.
Liang Cheng (2015)
10.1038/s41467-017-01050-0
Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
Guangbao Yang (2017)
10.1002/SMTD.202000566
Construction of Smart Manganese Dioxide‐Based All‐in‐One Nanoplatform for Cancer Diagnosis and Therapy
Xiangmei Liu (2020)
eview n the use of nanotechnology-based strategies for association of omplex matrices from plant extracts iovanni
Konat Zorzia (2015)
10.1002/ADFM.201600676
Modulation of Hypoxia in Solid Tumor Microenvironment with MnO2 Nanoparticles to Enhance Photodynamic Therapy
W. Zhu (2016)
10.1007/s40820-019-0305-x
Inorganic Nanozyme with Combined Self-Oxygenation/Degradable Capabilities for Sensitized Cancer Immunochemotherapy
J. Wang (2019)
10.1016/j.jconrel.2019.12.042
Mesoporous carbon‑manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy.
X. Li (2019)
10.1016/j.saa.2017.01.030
Characterization, catalyzed water oxidation and anticancer activities of a NIR BODIPY-Mn polymer.
Ya-Quan Lan (2017)
10.1016/j.biomaterials.2016.10.030
Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.
Shi Gao (2017)
10.1016/j.biomaterials.2019.119578
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia.
A. Sahu (2019)
10.1039/d0nj01251c
Dimerization of heavy atom free tetraphenylethylene with aggregation induced emission for boosting photodynamic therapy
Jianjiao Chen (2020)
10.1038/aps.2018.33
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples
R. Zhang (2018)
10.1039/d0nr04067c
Nanostructured manganese dioxide for anticancer applications: preparation, diagnosis, and therapy.
Z. Zhang (2020)
10.1039/C8NH00191J
Advances in controlled gas-releasing nanomaterials for therapeutic applications
D. Manoharan (2019)
10.1016/j.nantod.2020.100965
Multifunctional bioreactive-nanoconstructs for sensitive and accurate MRI of cerebrospinal fluid pathology and intervention of Alzheimer’s disease
Chunsheng He (2020)
10.1016/J.CCLET.2017.05.023
H2O2-responsive theranostic nanomedicine
Luodan Yu (2017)
10.1039/c9nr06513j
Controllable growth of Au nanostructures onto MoS2 nanosheets for dual-modal imaging and photothermal-radiation combined therapy.
Teng Liu (2019)
10.1021/acsnano.8b04544
Near-Infrared-Triggered in Situ Gelation System for Repeatedly Enhanced Photothermal Brachytherapy with a Single Dose.
Zhouqi Meng (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar